You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (195)

Journals (0)

1-10 of 195 results for TKI-treated

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: New EGFR-TKI: A case report of recurrent lung adenocarcinoma successfully treated with icotinib

Retricted access

Research article

First published 2012-07

New EGFR-TKI: A case report of recurrent lung adenocarcinoma successfully treated with icotinib

Yulong Zheng, Weijia Fang, Xiao Liu [...]

Tumori Journal

Select article: Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis

Retricted access

Research article

First published 2025-10

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis

Marco Stellato, Ernesto Zecca, Paola Bracchi [...]

Tumori Journal

Select article: Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR -mutated non-small-cell lung cancer: a retrospective,multicenter cohort study

Open access

Research article

First published 2024

Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR -mutated non-small-cell lung cancer: a retrospective,multicenter cohort study

Ichidai Tanaka, Kazumi Hori, Junji Koyama [...]

Therapeutic Advances in Medical Oncology

Select article: Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide,Population-Based Cohort Study

Open access

Research article

First published 2019

Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide,Population-Based Cohort Study

Chia-Ling Li, Te-Chun Hsia, Chia-Hsiang Li [...]

Integrative Cancer Therapies

Select article: Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Open access

Research article

First published 2024

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang [...]

Therapeutic Advances in Medical Oncology

Select article: Cardiac Metastasis from Renal Cell Carcinoma Successfully Treated with Pazopanib: Impact of TKIs' Antiangiogenic Activity

Retricted access

Research article

First published 2014-11

Cardiac Metastasis from Renal Cell Carcinoma Successfully Treated with Pazopanib: Impact of TKIs' Antiangiogenic Activity

Giovanni Schinzari, Santa Monterisi, Diego Signorelli [...]

Tumori Journal

Select article: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer

Open access

Research article

First published 2024

EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer

Fei Ye, Xiao Yuan, Wanjun Yu [...]

Technology in Cancer Research & Treatment

Select article: The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs

Open access

Research article

First published 2021-4

The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs

Qiong He, Yamin Li, Xihong Zhou [...]

Journal of International Medical Research

Select article: Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs

Open access

Research article

First published 2025

Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs

Caifeng Gong, Jinglong Huang, Dandan Cao [...]

Therapeutic Advances in Medical Oncology

Select article: Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer

Open access

Letter

First published 2024

Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer

Hinpetch Daungsupawong, Viroj Wiwanitkit

Technology in Cancer Research & Treatment

1
2
3
•••
20
10 / page

Article type

Publication date

Subjects

Access